Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Vetter Pharma is a globally leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges, and vials, as well as the assembly of pens, autoinjectors, and other complex drug delivery systems. With decades of experience, Vetter supports pharmaceutical and biotech companies worldwide, from early-stage clinical development through to commercial manufacturing and market launch. The company is recognized for its high-quality standards, innovation in drug delivery, and commitment to patient safety.
The Ravensburg headquarters serves as the central hub for corporate management, global strategy, research and development, as well as being a major site for aseptic manufacturing and administrative operations.
State-of-the-art aseptic filling lines, advanced cleanroom technology, modern R&D laboratories, and comprehensive quality control facilities. The sites are designed to meet stringent international pharmaceutical manufacturing standards.
Emphasizes precision, quality, innovation, and reliability, fostering a collaborative environment focused on employee development and delivering high-quality solutions for pharmaceutical and biotech partners. A strong commitment to 'Made in Germany' quality standards and continuous improvement.
The Ravensburg headquarters is the historical and operational core of Vetter, driving its global leadership in aseptic fill/finish services and embodying its commitment to quality and innovation in pharmaceutical manufacturing. It's where the company's journey began and continues to be a center for expertise.
Vetter Pharma supports global pharmaceutical and biotech companies with a comprehensive range of services. These include drug product development, aseptic fill and finish of syringes, vials, and cartridges, clinical trial manufacturing, commercial manufacturing, and specialized packaging solutions. Its global functions span from R&D and manufacturing primarily in Germany (Ravensburg, Langenargen) and the US (Skokie, IL and a future site in Des Plaines, IL), and secondary packaging in Austria (Rankweil), to sales, business development, and customer support offices strategically located in key markets across Europe, North America, and Asia-Pacific (including Japan, China, South Korea, and Singapore).
Eywiesenstrasse 5
Ravensburg
Baden-Württemberg
Germany
Address: Illinois Science + Technology Park, 8030 Lamon Avenue, Suite 1400, Skokie, IL 60077, USA
Serves as Vetter's North American hub for clinical manufacturing, offering proximity and specialized services to the vibrant biotech and pharmaceutical ecosystem in the US, particularly for early-phase drug development projects.
Address: Graf-Maximilian-Strasse 11, 6830 Rankweil, Austria
Provides advanced secondary packaging solutions and complements Vetter's aseptic filling capabilities, ensuring end-to-end service for drug products destined for global distribution.
Address: Vetter Pharma International GmbH Singapore Branch, 10 Eunos Road 8, #13-06 Singapore Post Centre, Singapore 408600
Supports Vetter's engagement with pharmaceutical and biotech companies across the APAC region, providing local expertise, market insights, and access to Vetter's global manufacturing network.
Address: 1500 S. Mount Prospect Road, Des Plaines, IL 60018, USA (Future Site)
Represents a major strategic investment to bolster Vetter's presence and service offerings in North America, addressing growing demand for high-quality clinical fill/finish services.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Vetter Pharma' leadership includes:
Vetter Pharma has been backed by several prominent investors over the years, including:
In the past 12 months, Vetter Pharma announced the appointment of Oliver Albrecht as a new Managing Director, effective March 2024, to strengthen its leadership team. No prominent executive departures were publicly announced during this period.
Discover the tools Vetter Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Vetter Pharma commonly uses the email format firstname.lastname@vetter-pharma.com for its employees. This structure is typical for professional communication within the organization and facilitates direct contact with specific individuals.
firstname.lastname@vetter-pharma.com
Format
jane.doe@vetter-pharma.com
Example
85%
Success rate
Fierce Pharma • May 14, 2024
Vetter announced a significant investment of $600 million to build a new, state-of-the-art clinical manufacturing site in Des Plaines, Illinois. This strategic expansion aims to substantially increase its capacity for early-stage drug development support for customers in the US market....more
Vetter Pharma Official Website • February 20, 2024
Vetter reported record sales for the fiscal year 2023, demonstrating strong global demand for its CDMO services. The company outlined plans to continue its growth trajectory through ongoing investments in capacity expansion, technological advancements, and sustainability initiatives....more
Vetter Pharma Official Website • November 16, 2023
Vetter announced the appointment of Oliver Albrecht as a new Managing Director, effective March 1, 2024. He will join existing Managing Directors Thomas Otto and Peter Soelkner, bringing extensive industry experience to further strengthen the company's leadership and strategic execution....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Vetter Pharma, are just a search away.